In addition, gene therapy for ALS has also been successfully administered in an ALS mouse model by intramuscular injection of AAV to express human Dok-7, a crucial muscle protein involved in NMJ formation [72]. The gene discussed is DOK7; the disease is amyotrophic lateral sclerosis.